Login / Signup

Chemotherapy and COVID-19 Outcomes in Patients With Cancer.

Justin JeeMichael B FooteMelissa A LumishAaron James StonestromBeatriz WillsVarun NarendraViswatej AvutuYonina R Murciano-GoroffJason E ChanAndriy DerkachJohn PhilipRimma BelenkayaMarina KerpelevMolly MaloyAdam WatsonChris FongYelena JanjigianLuis A DiazKelly L BoltonMelissa S Pessin
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)
Recent cytotoxic chemotherapy treatment was not associated with adverse COVID-19 outcomes. Patients with active hematologic or lung malignancies, peri-COVID-19 lymphopenia, or baseline neutropenia had worse COVID-19 outcomes. Interactions among antineoplastic therapy, cancer type, and COVID-19 are complex and warrant further investigation.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • stem cells
  • emergency department
  • locally advanced
  • radiation therapy
  • metabolic syndrome
  • rectal cancer
  • cell therapy
  • smoking cessation